Table 3.
BRAF V600E mutation | First diagnosis | |
---|---|---|
PXA (n = 51) | PXA‐AF (n = 23) | |
Final status | ||
Mutant | 30 (73.2%) | 9 (47.4%) |
Nonmutant | 10 (24.4%) | 10 (52.6%) |
Indeterminate | 1 (2.4%) | 0 |
NA | 10 | 4 |
By immunohistochemistry | ||
Positive | 30 (73.2%) | 9 (47.4%) |
Negative | 10 (24.4%) | 6 (31.6%) |
Indeterminate | 1 (2.4%) | 4 (21.1%) |
NA | 10 | 4 |
By molecular genetics | ||
Mutant | 18 (69.2%) | 6 (46.2%) |
Nonmutant | 8 (30.8%) | 7 (53.8%) |
NA | 25 | 10 |